Marketa Skala

Hobart, TAS, AU 
Hobart, TAS, AU 

Overview

Marketa Skala practices practicing medicine in Hobart, Australia.

Her clinical expertise encompasses Pulmonary Sequestration, Familial Prostate Cancer, and Prostate Cancer.

She is actively involved in clinical research, co-authoring 20 peer reviewed articles and participating in 4 clinical trials.

Gender

Female

Locations

Hobart, TAS 7000, Australia
Other Locations
Launceston, TAS, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Randomised Phase 3 Trial of Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer: ENZARAD
Randomised Phase 3 Trial of Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer: ENZARAD
Enrollment Status: Active_not_recruiting
Publish Date: May 06, 2026
Intervention Type: Drug, Radiation
Study Drugs: Enzalutamide, Conventional NSAA, LHRHA
Study Phase: Phase 3
A Randomised Comparison of Anastrozole Commenced Before and Continued During Adjuvant Radiotherapy for Breast Cancer Versus Anastrozole and Subsequent Anti-oestrogen Therapy Delayed Until After Radiotherapy.
A Randomised Comparison of Anastrozole Commenced Before and Continued During Adjuvant Radiotherapy for Breast Cancer Versus Anastrozole and Subsequent Anti-oestrogen Therapy Delayed Until After Radiotherapy.
Enrollment Status: Unknown
Publish Date: November 18, 2022
Intervention Type: Drug, Radiation
Study Drugs: Pre-Radiotherapy Commencement of Anastrozole, Post Radiotherapy Commencement of Anastrozole
Study Phase: Phase 3
IDH Mutated 1p/19q Intact Lower Grade Glioma Following Resection: Wait Or Treat? IWOT - a Phase III Study
IDH Mutated 1p/19q Intact Lower Grade Glioma Following Resection: Wait Or Treat? IWOT - a Phase III Study
Enrollment Status: Terminated
Publish Date: February 01, 2022
Intervention Type: Radiation, Drug, Procedure
Study Drug: Temozolomide
Study Phase: Phase 3
A Randomised Phase II Trial of Adaptive Image Guided Standard or Dose Escalated Tumour Boost Radiotherapy in the Treatment of Transitional Cell Carcinoma of the Bladder
A Randomised Phase II Trial of Adaptive Image Guided Standard or Dose Escalated Tumour Boost Radiotherapy in the Treatment of Transitional Cell Carcinoma of the Bladder
Enrollment Status: Active_not_recruiting
Publish Date: June 09, 2020
Intervention Type: Radiation
Study Phase: Phase 2
View 3 Less Clinical Trials

20 Total Publications

Prostate Cancer Disparities Between Public and Private Healthcare Patients in Tasmania, a Regional State of Australia.
Prostate Cancer Disparities Between Public and Private Healthcare Patients in Tasmania, a Regional State of Australia.
Journal: Cancers
Published: November 20, 2025

Frequently Asked Questions about Marketa Skala

Is Marketa Skala a top-rated expert for Pulmonary Sequestration?

MediFind is an objective health platform that identifies experts based on real-world data. Marketa Skala is classified as an Experienced expert for Pulmonary Sequestration, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Marketa Skala participate in research or clinical trials?

Yes. Marketa Skala has published 20 articles and abstracts on conditions like Pulmonary Sequestration. You can view a list of Marketa Skala's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Skala's expertise for a condition
ConditionClose
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile